- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 15/13 - Immunoglobulins
Patent holdings for IPC class C12N 15/13
Total number of patents in this class: 7022
10-year publication summary
|
239
|
270
|
377
|
557
|
641
|
711
|
616
|
463
|
534
|
392
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Chugai Seiyaku Kabushiki Kaisha | 1422 |
123 |
| Shanghai Hengrui Pharmaceutical Co., Ltd. | 712 |
82 |
| Daiichi Sankyo Company, Limited | 1893 |
71 |
| National Research Council of Canada | 1551 |
67 |
| Regeneron Pharmaceuticals, Inc. | 4698 |
61 |
| Innovent Biologics (Suzhou) Co., Ltd. | 291 |
61 |
| Amgen Inc. | 4425 |
56 |
| Zymeworks Inc. | 253 |
54 |
| Genentech, Inc. | 4099 |
51 |
| Jiangsu Hengrui Medicine Co., Ltd. | 694 |
47 |
| The University of Tokyo | 4352 |
43 |
| Wuxi Biologics (Shanghai) Co. Ltd. | 173 |
40 |
| Janssen Biotech, Inc. | 1762 |
39 |
| F. Hoffmann-La Roche AG | 7836 |
38 |
| Jiangsu Hengyi Pharmaceutical Co., Ltd. | 356 |
38 |
| Biotheus Inc. | 78 |
38 |
| WuXi Biologics Ireland Limited | 283 |
37 |
| Biocytogen Pharmaceuticals (Beijing) Co., Ltd | 229 |
32 |
| Joint Stock Company "BIOCAD" | 220 |
31 |
| The University of British Columbia | 1537 |
31 |
| Other owners | 5982 |